Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 7876 AL 7890

CREB: A Multifaceted Target for Alzheimer's Disease

Sharma VK, Singh TG.

Curr Alzheimer Res. 2020;17(14):1280-1293. doi: 10.2174/1567205018666210218152253.

Altered Gut Microbiota Related to Inflammatory Responses in Patients With Huntington's Disease

Du G, Dong W, Yang Q, Yu X, Ma J, Gu W, Huang Y.

Front Immunol. 2021 Feb 19;11:603594. doi: 10.3389/fimmu.2020.603594. eCollection 2020.

Rapidly Progressing Neurocognitive Disorder in a Male with FXTAS and Alzheimer's Disease

Aydin EY, Schneider A, Protic D, Wang JY, Martínez-Cerdeño V, Tassone F, Tang HT, Perlman S, Hagerman RJ.

Clin Interv Aging. 2020 Feb 26;15:285-292. doi: 10.2147/CIA.S240314. eCollection 2020.

Progressive ataxia and cognitive decline in a 67-year-old male: a diagnostic challenge

Osman D, Weidner A, Madhra M.

J R Coll Physicians Edinb. 2020 Sep;50(3):281-283. doi: 10.4997/JRCPE.2020.313.

Repeat RNA expansion disorders of the nervous system: post-transcriptional mechanisms and therapeutic strategies

Schwartz JL, Jones KL, Yeo GW.

Crit Rev Biochem Mol Biol. 2021 Feb;56(1):31-53. doi: 10.1080/10409238.2020.1841726. Epub 2020 Nov 10.

Motoric cognitive risk syndrome and predictors of transition to dementia: A multicenter study

Verghese J, Wang C, Bennett DA, Lipton RB, Katz MJ, Ayers E.

Alzheimers Dement. 2019 Jul;15(7):870-877. doi: 10.1016/j.jalz.2019.03.011. Epub 2019 Jun 1.

Meta-Analysis of Gene Expression Changes in the Blood of Patients with Mild Cognitive Impairment and Alzheimer's Disease Dementia

Bottero V, Potashkin JA.

Int J Mol Sci. 2019 Oct 30;20(21):5403. doi: 10.3390/ijms20215403.

Factors Associated with Alzheimer's Disease: An Overview of Reviews

Rochoy M, Rivas V, Chazard E, Decarpentry E, Saudemont G, Hazard PA, Puisieux F, Gautier S, Bordet R.

J Prev Alzheimers Dis. 2019;6(2):121-134. doi: 10.14283/jpad.2019.7.

Consecutive sessions of transcranial direct current stimulation do not remediate visual hallucinations in Lewy body dementia: a randomised controlled trial

Elder GJ, Colloby SJ, Firbank MJ, McKeith IG, Taylor JP.

Alzheimers Res Ther. 2019 Jan 18;11(1):9. doi: 10.1186/s13195-018-0465-9.

Lewy Body Dementias

Armstrong MJ.

Continuum (Minneap Minn). 2019 Feb;25(1):128-146. doi: 10.1212/CON.0000000000000685.

Tactile hallucinations in dementia with Lewy bodies

Ukai K.

Psychogeriatrics. 2019 Sep;19(5):435-439. doi: 10.1111/psyg.12407. Epub 2019 Feb 7.

Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study

Postuma RB, Iranzo A, Hu M, Högl B, Boeve BF, Manni R, Oertel WH, Arnulf I, Ferini-Strambi L, Puligheddu M, Antelmi E, Cochen De Cock V, Arnaldi D, Mollenhauer B, Videnovic A, Sonka K, Jung KY, Kunz D, Dauvilliers Y, Provini F, Lewis SJ, Buskova J, Pavlova M, Heidbreder A, Montplaisir JY, Santamaria J, Barber TR, Stefani A, St Louis EK, Terzaghi M, Janzen A, Leu-Semenescu S, Plazzi G, Nobili F, Sixel-Doering F, Dusek P, Bes F, Cortelli P, Ehgoetz Martens K, Gagnon JF, Gaig C, Zucconi M, Trenkwalder C, Gan-Or Z, Lo C, Rolinski M, Mahlknecht P, Holzknecht E, Boeve AR, Teigen LN, Toscano G, Mayer G, Morbelli S, Dawson B, Pelletier A.

Brain. 2019 Mar 1;142(3):744-759. doi: 10.1093/brain/awz030.

Current treatment of behavioral and cognitive symptoms of Parkinson's disease

Rektorova I.

Parkinsonism Relat Disord. 2019 Feb;59:65-73. doi: 10.1016/j.parkreldis.2019.02.042. Epub 2019 Feb 28.

Toxoplasma gondii infection and risk of Parkinson and Alzheimer diseases: A systematic review and meta-analysis on observational studies

Bayani M, Riahi SM, Bazrafshan N, Ray Gamble H, Rostami A.

Acta Trop. 2019 Aug;196:165-171. doi: 10.1016/j.actatropica.2019.05.015. Epub 2019 May 15.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias